Kajian Terkini CoronaVirus Disease 2019 (COVID-19)

Authors

  • Chicy Widya Morfi
  • Ahmad Junaidi Fakultas Kedokteran Universitas Andalas
  • Elsesmita Elsesmita Fakultas Kedokteran Universitas Andalas
  • Diana Nur Asrini Fakultas Kedokteran Universitas Andalas
  • Dya Mulya Lestari Fakultas Kedokteran Universitas Andalas
  • Irvan Medison Fakultas Kedokteran Universitas Andalas
  • Russilawati Russilawati Fakultas Kedokteran Universitas Andalas
  • Fauzar Fauzar Fakultas Kedokteran Universitas Andalas
  • Roza Kurniati Fakultas Kedokteran Universitas Andalas
  • Finny Fitry Yani Fakultas Kedokteran Universitas Andalas

DOI:

https://doi.org/10.25077/jikesi.v1i1.13

Keywords:

Covid-19

Abstract

The COVID-19 outbreak in Wuhan, Hubei Province, China, caused by a newly known coronavirus strain, SARS-CoV-2, up to March 3th, 2020, has caused 90.870 confirmed cases to be reported from 72 countries (including Indonesia) with 3.112 deaths (CFR 3,4%). Upper airway swab and lower airway aspirate specimens from suspected patients are required for examination by the RT-PCR microbiological method for establishing COVID-19. There are no specific antivirals for the management of COVID-19. On January, 30th, 2020 WHO has established Covid-19 as the Public Health Emergency of International Concern (PHEIC), but the increase in the number of cases is fast enough so that on March,11th 2020, WHO has established Covid-19 as a pandemic.

Downloads

Published

2020-03-21

How to Cite

Morfi, Chicy Widya, et al. “Kajian Terkini CoronaVirus Disease 2019 (COVID-19)”. Jurnal Ilmu Kesehatan Indonesia, vol. 1, no. 1, Mar. 2020, doi:10.25077/jikesi.v1i1.13.

Issue

Section

Research Articles